Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
24.02
-0.25 (-1.03%)
At close: Mar 9, 2026
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 2.69 billion as of March 10, 2026. Its market cap has increased by 38.64% in one year.
Market Cap
2.69B
Enterprise Value
1.91B
Revenue
196.21M
Ranking
n/a
PE Ratio
51.88
Stock Price
24.02
Market Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 2.69B, a decrease of -54.97%. That is a compound annual growth rate of -18.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 2.69B | 14.38% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu CoWin Biotech | 2.59B |
| Jilin Jian Yisheng Pharmaceutical | 2.83B |
| Zhejiang East Asia Pharmaceutical | 2.56B |
| Shandong Sito Bio-technology | 2.84B |
| Novoprotein Scientific | 2.86B |
| Shanghai Universal Biotech | 2.88B |
| Jiangsu Sihuan Bioengineering | 2.88B |
| Guiyang Xintian Pharmaceutical | 2.43B |